Whalegun
Home

Mark Hopman, Chief Commercial Officer: Beta Bionics BBNX Sell · Filed 25/08/20

Trade details

Type
Insider sale
Amount
$268,384.38
Shares · price
16,158 sh · $16.61 a share
Held after
34,132 sh
Stock
Beta Bionics BBNX
Person
Mark HopmanChief Commercial Officer
Trade date
25/08/19
Filed
25/08/20
Days to filing
1 days

Sold 32.1% of holdings

Share of holding sold
32.1%

Beta Bionics trades, last 26 weeks

What else happened in Beta Bionics around then

Filed or reported within 30 days of the trade day · 25/07/20~25/09/18

Mark Hopman's recent trades

  • Mark Hopman

    Planned sale10b5-1 planBeta Bionics

    $540.7K

    Filed 09/16

  • Mark Hopman

    Planned sale10b5-1 planBeta Bionics

    $779.1K

    Filed 09/09

  • Mark Hopman

    Planned saleBeta Bionics

    $103.4K

    Filed 09/03

  • Mark Hopman

    Sell10b5-1 planBeta Bionics

    $18.9K

    Filed 06/25

  • Mark Hopman

    Planned sale10b5-1 planBeta Bionics

    $18.8K

    Filed 06/24

Mark Hopman, Chief Officer — sold $268.4K of Beta Bionics BBNX · 32.1% of holdings · 10b5-1 plan | Whalegun